期刊文献+

3-乙酰基-4-乙酰氧基苯并噁唑-2-酮对四氯化碳致小鼠急性肝损伤的保护作用 被引量:2

Protective Effect of 3-Acetyl-4-acetoxy-2-benzoxazolone against Acute Liver Injury Induced by Carbon Tetrachloride in Mice
原文传递
导出
摘要 目的观察3-乙酰基-4-乙酰氧基苯并噁唑-2-酮(3-acetyl-4-acetoxy-2-benzoxazolone,TC-3)对四氯化碳所致小鼠急性肝损伤的保护作用,并探讨其疗效机制。方法采用腹腔注射体积分数0.15%四氯化碳制备小鼠急性肝损伤模型,3-乙酰基-4-乙酰氧基苯并噁唑-2-酮各剂量组灌胃给药,检测不同剂量的3-乙酰基-4-乙酰氧基苯并噁唑-2-酮对肝损伤小鼠血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶活性以及肝组织匀浆中超氧化物歧化酶活性、丙二醛和还原型谷胱甘肽含量的影响,同时光镜下观察肝组织的病理变化。结果 3-乙酰基-4-乙酰氧基苯并噁唑-2-酮能明显降低四氯化碳致急性肝损伤小鼠血清血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶的活性,降低肝匀浆丙二醛的含量,同时提高肝组织中超氧化物歧化酶、谷胱甘肽的活性,并能减轻四氯化碳对肝组织的病理损伤。结论 3-乙酰基-4-乙酰氧基苯并噁唑-2-酮对四氯化碳致小鼠急性肝损伤具有一定的保护作用,其保护机制可能与清除自由基、抗脂质过氧化作用有关。 OBJECTIVE To study the protective effect of 3-aeetyl- 4-aeetoxy-2-benzoxazolone on liver injury induced by carbon tetrachloride ( CCl4 ) in mice. METHODS The serum activities of ALT and AST and the levels of MDA, SOD and GSH in liver tissue were measured in the model of acute liver injury induced by intraperitoneal injection 0. 15% CCl4 and hepatic histological changes were observed by optical microscope. RESULTS Compared with control group, the serum ALT, AST and the liver tissue MDA activities were significantly lowered, the levels of SOD and GSH in liver tissue were increased obviously. Histological results showed that 3-ace- tyl- 4-acetoxy-2-benzoxazolone could ameliorate histological damages induced by CCl4 in mice. CONCLUSION 3-Aeetyl- 4-aeetoxy- 2-benzoxazolone exhibits protective effects on experimental hepatic injury.
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第22期1813-1816,共4页 Chinese Pharmaceutical Journal
基金 广西自然科学基金资助项目(2009AM4019)
关键词 3-乙酰基4-乙酰氧基苯并噁唑-2-酮 急性肝损伤 四氯化碳 3-acetyl- 4-aeetoxy-2-benzoxazolone acute liver injury CCl4
  • 相关文献

参考文献9

  • 1Jiangsu New Medical College. Dictionary of Chinese Traditional Drugs(中药大辞典)[M].Shanghai: Shanghai Scientific and Technical Publishers, 1986:844.
  • 2CHEN Y H. Study on the synthesis and anti-inflamatory and anal- gesic activities of the N-substituent derivatives of acetyl ilicifolius alkaloidsa[ D]. Pharmacy College of Guangxi Medical University, 2009.
  • 3LIN P. The Characteristics of Mangrove Wetlands and Some Eco- logical Engineering Questions in China [ D ]. Shanghai : Shanghai Institute of Microsystem and Information Technology, Chinese A- cademy of Sciences,2000.
  • 4彭兴,龙盛京.老鼠簕提取成分的抗氧化活性[J].华西药学杂志,2006,21(1):14-17. 被引量:16
  • 5厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446. 被引量:252
  • 6SHERLOCK S. Progress report hepatic reaction to drugs [ J ]. Gut, 1999,20 (4) :634-642.
  • 7BOLL M, WEBER L W, BECKER E, et al. Mechanism of car- bon-tetrachloride induced hepatotoxicity [ J ]. Z Naturforsch , 2001, 56 ( 7-8 ) :649-659.
  • 8张国升,凡明月,彭代银,方方.芦根多糖对四氯化碳小鼠肝损伤的保护作用[J].中国药理学通报,2002,18(3):354-355. 被引量:29
  • 9LIN P. Mangrove Ecosystem in China(扣国红树林生态系)[M].Beijing: Science Press,1997.

二级参考文献11

  • 1杨旭辉,朱敏恒,吴越.植物源性天然抗氧化成分研究进展[J].农垦医学,2004,26(4):298-300. 被引量:20
  • 2夏奕明 朱莲珍.血和组织中谷胱甘肽过氧化酶的测定方法[J].卫生研究,1987,16(4):29-31.
  • 3巫饮海.芦根治疗肝炎[J].吉林中医学,1997,4:34-34.
  • 4周世清 尹才渊 等.赶黄草对实验性肝损伤的影响[J].中药与临床,1987,3(3):16-7.
  • 5Babu BH, Shylesh BS, Padikkala. Antioxdant and hepatopro- tective effect of Acanthus ilicifolius [J]. India Fitoterapia,2001, 72:272.
  • 6Babu BH, Shylesh BS, Padikkala, Tumour reduceing and anticareinogenic activity of Acanthus ilcifolius in mice [J]. India Journal of Ethnopharmacology, 2002,79: 27.
  • 7Starke PE, Farber JL. Endogenous defenses against the cytotoxicity of hydrogen peroxide in cultured rat hepatocytes [J]. J Biol Chem,1985,260(1):86.
  • 8国家中医药管理局.中华本草(下)[M].上海:上海科学技术出版社,1998.2159.
  • 9江苏新医学院.中药大辞典[M].上海:上海科学技术出版社,1999.1474.
  • 10江苏新医学院.中药大辞典[M].上海:上海科技出版社,1986.739.

共引文献293

同被引文献20

  • 1刘春宇,顾振纶,张克平,周文轩,郭次仪.沙苑子黄酮抗CCl_4大鼠肝纤维化作用及对IFN-γ,TGF-β_1的影响[J].中国药学杂志,2004,39(12):910-912. 被引量:14
  • 2Liver Disease Committee,Chinese Association of Integrative Medicine..肝纤维化中西医结合诊疗指南[J].中华肝脏病杂志,2006,14(11):866-870. 被引量:270
  • 3孙楠,高尚先.肝纤维化的形成机制、动物模型及治疗进展[J].药物分析杂志,2007,27(3):470-475. 被引量:3
  • 4张艳,都广礼,陈德兴,陈少丽.猪血清致大鼠免疫性肝纤维化的动态观察[J].中国中西医结合消化杂志,2007,15(2):74-77. 被引量:10
  • 5BABU B H, SHYLESH B S, PADIKKALA J. Antioxidant and hepatoprotective effect of Acanthus ilicifolius. Fitoterapia,2001, 72(3):272-277.
  • 6GANESH S, VENNILA J J. Screening for Antimicrobial Activity in Acanthus ilicifolius. Arch Appl Sci Res, 2010, 2(5):311-315.
  • 7BABU B H, SHYLESH B S, PADIKKALA J. Tumour reducing and anticarcinogenic activity of Acanthus ilicifolius in mice. J Ethnopharmacol,2002, 79(1):27-33.
  • 8GULCAN H O, KUPELI E, UNLU S, et al. 4-(5-chloro-2(3H)-benzoxazolon-3-yl)butanoic acid derivatives: Synthesis, antinociceptive and anti-inflammatory properties. Arch Pharm,2003, 336(10):477-482.
  • 9GU X H, FANG D C. Regulation of hepatic stellate cell activation and proliferation and collagen synthesis by protease activated receptors and Role of protease receptors in liver fibrosis . 世界华人消化杂志,2006,19(5):502-507.
  • 10LIU H, WEI W, SUN W Y, et al. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J Ethnopharmacol, 2009, 122(3):502-508.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部